Vonoprazan Fumarate, a novel proton pump inhibitor (PPI), has emerged as a promising treatment for gastrointestinal disorders. As a manufacturer or supplier, venturing into the global market for Vonoprazan Fumarate presents exciting opportunities. This guide equips you with the knowledge and strategies to connect with international buyers for this revolutionary drug. Identifying Promising Markets The global market for Vonoprazan Fumarate is expected to witness significant growth due to factors like: Rising prevalence of gastric disorders: Globally, the incidence of gastroesophageal reflux disease (GERD) and peptic ulcers is on the rise, creating a demand for effective treatments. Growing adoption of novel PPIs: Healthcare providers are increasingly seeking advanced PPIs with improved…